N Square Biotech Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 22-06-2024
- Paid Up Capital ₹ 0.10 M
as on 22-06-2024
- Company Age 5 Year, 7 Days
- Last Filing with ROC 31 Mar 2023
- Revenue 25868.29%
(FY 2022)
- Profit 100.33%
(FY 2022)
- Ebitda -2279.89%
(FY 2022)
- Net Worth 0.47%
(FY 2022)
- Total Assets -17.71%
(FY 2022)
About N Square Biotech
The Company is engaged in the Real Estate And Construction Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Gaurang Mody, Soham Modi, and Tejal Modi serve as directors at the Company.
- CIN/LLPIN
U70109TG2019PTC137599
- Company No.
137599
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Dec 2019
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at N Square Biotech?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Soham Modi  | Director | 13-Dec-2019 | Current |
| Gaurang Mody | Director | 28-Oct-2021 | Current |
| Tejal Modi | Director | 13-Dec-2019 | Current |
Financial Performance and Corporate Structure Insights of N Square Biotech.
N Square Biotech Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 25868.29% increase. The company also saw a substantial improvement in profitability, with a 100.33% increase in profit. The company's net worth moved up by a moderate rise of 0.47%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of N Square Biotech?
Unlock access to N Square Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Modi Housing Private LimitedActive 21 years 11 monthsGaurang Mody, Soham Modi and 1 more are mutual person
- Modi Properties Private LimitedActive 30 years 5 months
Gaurang Mody, Soham Modi and 1 more are mutual person
- Modi & Modi Realty Hyderabad Private LimitedActive 4 years 11 months
Gaurang Mody and Soham Modi are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at N Square Biotech?
Unlock and access historical data on people associated with N Square Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of N Square Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped N Square Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
